Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis.

Blood
Andres JerezJaroslaw P Maciejewski

Abstract

Loss of heterozygosity affecting chromosome 7q is common in acute myeloid leukemia and myelodysplastic syndromes, pointing toward the essential role of this region in disease phenotype and clonal evolution. The higher resolution offered by recently developed genomic platforms may be used to establish more precise clinical correlations and identify specific target genes. We analyzed a series of patients with myeloid disorders using recent genomic technologies (1458 by single-nucleotide polymorphism arrays [SNP-A], 226 by next-generation sequencing, and 183 by expression microarrays). Using SNP-A, we identified chromosome 7q loss of heterozygosity segments in 161 of 1458 patients (11%); 26% of chronic myelomonocytic leukemia patients harbored 7q uniparental disomy, of which 41% had a homozygous EZH2 mutation. In addition, we describe an SNP-A-isolated deletion 7 hypocellular myelodysplastic syndrome subset, with a high rate of progression. Using direct and parallel sequencing, we found no recurrent mutations in typically large deletion 7q and monosomy 7 patients. In contrast, we detected a markedly decreased expression of genes included in our SNP-A defined minimally deleted regions. Although a 2-hit model is present in most pati...Continue Reading

References

Mar 1, 1994·Blood·J M Goldman
Jun 17, 2006·Blood·Neal S YoungPhillip Scheinberg
Jan 19, 2008·Nature·Benjamin L EbertTodd R Golub
May 29, 2008·The Journal of Pathology·A MiddeldorpH Morreau
May 29, 2009·The New England Journal of Medicine·François DelhommeauOlivier A Bernard
Sep 23, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ramon V TiuJaroslaw P Maciejewski
Apr 7, 2010·Leukemia Research·Ana Belén GalvánFrancesc Solé
Jul 6, 2010·Nature Genetics·Thomas ErnstNicholas C P Cross
Aug 21, 2010·Leukemia·H MakishimaJ P Maciejewski
Nov 27, 2010·Haematologica·Esperanza SuchGuillermo F Sanz
Apr 16, 2011·British Journal of Haematology·Andrea PellagattiJacqueline Boultwood
Jul 1, 2011·Cancer·Iris CordobaUNKNOWN Spanish Myelodysplastic Syndrome Registry
Mar 1, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andres JerezJaroslaw P Maciejewski

❮ Previous
Next ❯

Citations

Jun 7, 2013·The New England Journal of Medicine·Miika MehineLauri A Aaltonen
Dec 10, 2013·Hematology·Rafael Bejar
Feb 9, 2013·Blood·Jacqueline Boultwood
Mar 13, 2014·PLoS Biology·Zubaidah M RamdzanAlain Nepveu
Jan 17, 2014·Leukemia·N HosonoJ P Maciejewski
Sep 6, 2014·Nature Reviews. Cancer·Zubaidah M Ramdzan, Alain Nepveu
Oct 5, 2015·Advances in Biological Regulation·Andrea PellagattiJacqueline Boultwood
Dec 18, 2012·British Journal of Haematology·Yishai Ofran, Jacob M Rowe
Jun 7, 2014·British Journal of Haematology·Guillermo Montalbán BravoGuillermo García-Manero
Apr 9, 2016·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Rashmi S GoswamiGuilin Tang
Aug 21, 2016·Mutation Research. Reviews in Mutation Research·Bani Bandana Ganguly, N N Kadam
Apr 5, 2018·Blood·Toshiya InabaHirotaka Matsui
Aug 25, 2017·Nature Reviews. Cancer·Megan E McNerneyMichelle M Le Beau
May 17, 2019·International Journal of Clinical Oncology·Naoko Hosono
May 1, 2019·JCI Insight·Melisa Ruiz-GutierrezAkiko Shimamura
Jun 3, 2019·Biological Reviews of the Cambridge Philosophical Society·Adam F JohnsonReiner A Veitia
Feb 6, 2020·Internal Medicine·Hideaki Nakajima
Jan 24, 2015·Nature Reviews. Cancer·Ryuji HamamotoYusuke Nakamura
Dec 7, 2019·Hematology·Jibran Durrani, Jaroslaw P Maciejewski
Jul 19, 2017·Cellular and Molecular Life Sciences : CMLS·Mei-Ren PanWen-Chun Hung

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.